{"id":"W4388897642","doi":"10.1158/1078-0432.ccr-23-0133","title":"A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor–positive/HER2-negative Advanced or Metastatic Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Université Laval; Princess Margaret Cancer Centre","funders":"","keywords":"Dysgeusia; Fulvestrant; Medicine; Metastatic breast cancer; Internal medicine; Breast cancer; Tolerability; Exemestane; Aromatase inhibitor; Oncology; Cancer; Pharmacodynamics; Adverse effect; Estrogen receptor; Pharmacokinetics; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009208795,0.0001840882,0.0003922422,0.0001451664,0.0001250192,0.00001699305,0.0002613364,0.00008325631,0.0001039131],"category_scores_gemma":[0.0002608847,0.0001201965,0.00004745008,0.001077283,0.000406228,0.00001707692,0.0001743852,0.0004025925,0.000005420832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006364467,"about_ca_system_score_gemma":0.0006054962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008291794,"about_ca_topic_score_gemma":0.002651876,"domain_scores_codex":[0.9972311,0.0005749445,0.0005262976,0.0005880073,0.000656919,0.0004227526],"domain_scores_gemma":[0.9984392,0.0001620887,0.000161188,0.000365351,0.0006988265,0.0001733711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.419752,0.0528799,0.2950567,0.0002775691,0.002014037,0.0001100292,0.002543572,0.0005628687,0.04614263,0.00003001909,0.01139123,0.1692394],"study_design_scores_gemma":[0.1079949,0.1986176,0.6498295,0.0005367464,0.00008544091,0.000001386196,0.003256145,0.0001050277,0.03775435,0.00002949297,0.001107568,0.0006818391],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972005,0.00008427537,0.000008330857,0.0004244458,0.00006219353,0.001842633,0.0003228669,0.00001326102,0.00004142867],"genre_scores_gemma":[0.9979522,0.0004471712,0.0001171099,0.000051,0.00006421954,0.000708462,0.0001200432,0.00003501446,0.000504739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3547728,"threshold_uncertainty_score":0.490147,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07633842613163684,"score_gpt":0.4556095102528649,"score_spread":0.3792710841212281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}